Search - tctmd.com

Displaying 41 - 60 of 83

Sort: Relevancy | Date

News Industry News

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

September 16, 2014

Presentation TCT 2014

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Ulrich Hink

September 13, 2014

News Conference News ESC 2014

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Todd Neale

September 01, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Daily News

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

May 12, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Yael L. Maxwell

March 30, 2014

News Conference News ACC 2014

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Yael L. Maxwell

March 29, 2014

News Daily News

Bioengineered Vessels Appear Safe for Use in Dialysis Patients

November 21, 2013

News Conference News AHA 2013

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

Jason Kahn

November 17, 2013

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

Presentation TCT 2013

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Presenter: Murray Esler

October 29, 2013

News Conference News ESC 2013

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Caitlin E. Cox

September 04, 2013

News Daily News

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

July 19, 2013

News Daily News

EnligHTN I Published: Renal Denervation with Multielectrode Catheter Safe, Effective

Caitlin E. Cox

July 05, 2013

News Daily News

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

June 28, 2013

News Daily News

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

June 28, 2013

Advertisement

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

Renal Denervation Shows Promise in Patients Refractory to Stenting

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Bioengineered Vessels Appear Safe for Use in Dialysis Patients

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

Long-term Outcomes with Renal Denervation Show Sustained Benefit

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

EnligHTN I Published: Renal Denervation with Multielectrode Catheter Safe, Effective

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content